Dr Reddys Laboratories (RDY) Exchange Rate Effect (2009 - 2026)
Dr Reddys Laboratories (RDY) posted Exchange Rate Effect of $411947.6 for Q2 2026, down 81.57% on a QoQ basis from $2.2 million in Q3 2025, and down 80.08% year-over-year from $2.1 million in Q2 2025.
Analysis
Dr Reddys Laboratories (RDY) Exchange Rate Effect (2009 - 2026) Analysis & Trends
Dr Reddys Laboratories has reported Exchange Rate Effect for 17 years, with the latest figure at $411947.6 in Q2 2026.
- On a quarterly basis, Exchange Rate Effect fell 80.08% year-over-year to $411947.6 in Q2 2026; TTM through Jun 2026 was $4.4 million, a 265.62% increase from a year earlier, with the FY2026 full-year figure at $13.0 million, up 1200.0% from the prior year.
- Exchange Rate Effect was $411947.6 for Q2 2026 at Dr Reddys Laboratories, down from $2.2 million in the prior quarter.
- The five-year high for Exchange Rate Effect was $8.6 million in Q1 2022, with the low at -$3.3 million in Q4 2022.
- Average Exchange Rate Effect over 5 years is $1.2 million, with a median of $307869.3 recorded in 2024.
- The largest YoY upside for Exchange Rate Effect was 1361.29% in 2022 against a maximum downside of 3961.01% in 2022.
- Over 5 years, Exchange Rate Effect stood at -$3.3 million in 2022, then soared by 159.46% to $1.9 million in 2023, then slumped by 114.2% to -$274606.4 in 2024, then surged by 914.12% to $2.2 million in 2025, then sank by 81.57% to $411947.6 in 2026.
- The last three Exchange Rate Effect figures came in at $411947.6 (Q2 2026), $2.2 million (Q3 2025), and $2.1 million (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn | -5.00 Mn |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn | -3.30 Mn |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn | 411,947.57 |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn | -164,000.00 |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn | -2.00 Mn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | -2.13 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 67,000.00 |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn | 16,000.00 |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn | - |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 411,947.57 |
| Sep 30, 2025 | 2.24 Mn |
| Jun 30, 2025 | 2.07 Mn |
| Sep 30, 2024 | -274,606.38 |
| Jun 30, 2024 | 203,791.07 |
| Mar 31, 2024 | -782,700.71 |
| Dec 31, 2023 | 1.93 Mn |
| Sep 30, 2023 | -798,401.12 |
| Jun 30, 2023 | -1.08 Mn |
| Mar 31, 2023 | -1.07 Mn |
| Dec 31, 2022 | -3.25 Mn |
| Sep 30, 2022 | 1.61 Mn |
| Jun 30, 2022 | 6.65 Mn |
| Mar 31, 2022 | 8.62 Mn |
| Dec 31, 2021 | -80,079.58 |
| Sep 30, 2021 | -688,305.40 |
| Jun 30, 2021 | 1.93 Mn |
| Mar 31, 2021 | 589,739.67 |
| Dec 31, 2020 | 771,751.90 |
| Sep 30, 2020 | -738,472.31 |